
Chemical identity
Clopidogrel R-Enantiomer
CAS 444728-15-8 · C15H15ClN2OS
01Identity
Identifiers and names for this exact compound. Empty fields are left unassigned.
| Lazychem ID | LC-11303 |
|---|---|
| PubChem CID | 24991892 |
| Name | Clopidogrel R-Enantiomer |
| CAS RN | 444728-15-8 |
| Molecular formula | C15H15ClN2OS |
| Molecular weight | 306.81 g/mol |
| IUPAC name | ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide) |
| InChIKey | SRKXAUBVRPEIQR-CQSZACIVSA-N |
02Structure identifiers

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains at least one halogen atom. These statements are calculated from the published structure string.
| Defined stereocentres | 1 |
|---|---|
| Unassigned stereocentres | 0 |
| Ring count | 3 |
| Secondary amines | 0 |
| Tertiary amines | 1 |
| N-methyl amine sites | 0 |
| SMILES | C1CN(CC2=C1SC=C2)[C@H](C3=CC=CC=C3Cl)C(=O)N |
|---|---|
| InChI | Not listed |
| Formula from structure | C15H15ClN2OS |
| Molecular weight from structure | 306.81 g/mol |
03Stereochemistry
The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.
Published same-connectivity configurations
3 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

![Two-dimensional chemical structure of 2-Chlorophenyl-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetamide](/structures/pubchem/11312824-300.png)
2-Chlorophenyl-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetamide
CAS not listed
SRKXAUBVRPEIQR-UHFFFAOYSA-N
0 defined, 1 unassigned centres

Clopidogrel EP Impurity E / Clopidogrel Amide
CAS 444728-13-6
SRKXAUBVRPEIQR-AWEZNQCLSA-N
1 defined, 0 unassigned centres
Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
04India status for this compound
These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.
| NDPS / RCS | NO EXACT MATCH FOUND | CAS 444728-15-8 has no exact match in the reviewed published schedule. |
|---|---|---|
| SCOMET | NO EXACT REVIEWED CAS MATCH | CAS 444728-15-8 has no exact match in the reviewed SCOMET list. |
| Review date | 2026-08-01 | Recheck the current official instruments for the material, concentration, activity and date in question. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · reviewed 2026-08-01
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · reviewed 2026-08-01
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · reviewed 2026-08-01
05Names and relationships
Associated parent compound
Clopidogrel
View API and impurity familyOther names
- (R)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide
- 444728-15-8
- SCHEMBL5769131
- SRKXAUBVRPEIQR-CQSZACIVSA-N
- CS-0165242
- (r)-(-)-(2-chloro-phenyl)-(6,7-dihydro-4h-thieno[3,2-c]pyrid-5-yl)acetamide
- (R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide? (Clopidogrel Impurity pound(c)
- Clopidogrel Amide Racemate
- 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide
- Clopidogrel EP Impurity E
- Clopidogrel EP Impurity E / Clopidogrel Amide Racemate / 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide
06Documented history
Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.
No verified discovery, first report, occurrence, use or issue event is currently available for this identity.
07Sources
- S01PubChem compound record, CID 24991892
Names and machine-readable chemical identity properties.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. This page does not reproduce vendor descriptions or contributed narrative text.
- S03Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S04Controlled-substances notifications and amendments
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S05Appendix 3, SCOMET List
Directorate General of Foreign Trade, Government of India. Used for the exact-compound India status shown on this page.
